Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study

OBJECTIVE: To compare the merits and demerits of PEG-IFNα-2a and PEG-IFNα-2b for the treatment of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB). METHODS: Clinical files from eighty-four CHB patients admitted to the Second Hospital of Shanxi Medical University between January 2018...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Nina, Gao, Wei, Fan, Xiaohong, Gao, Hong, Li, Xueqing, Mi, Biantao, Yang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206564/
https://www.ncbi.nlm.nih.gov/pubmed/35726331
http://dx.doi.org/10.1155/2022/3185320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206564/
https://www.ncbi.nlm.nih.gov/pubmed/35726331
http://dx.doi.org/10.1155/2022/3185320

Ejemplares similares